Since March AstraZeneca has inked three significant deals with some lesser lights of the drugs sector quoted on the LSE’s alternative investment market.
Drugs giant inks collaboration deal with RenalytixAI
Something you may find interesting…
[recent_products per_page="4" columns="4" orderby="rand" order="rand"]